title: [A case of Stage IV non-operated advanced breast cancer with local recurrence thirteen years after initial therapy].
abstract: A 73-year-old woman underwent chemotherapy, radiotherapy, and hormonal therapies for right advanced breast cancer (T4, N3, M1, Stage IV) in 1993. She obtained a complete response in pathological evaluation (pCR) in 1998. For adjuvant therapies, she had been treated with hormonal therapies for five years until 2003. After the interruption of hormonal therapies, the serum levels of tumor markers had been elevated, and she had a right axillary local recurrence and a right ovarian metastasis detected by a FDG-PET/CT in February 2006. The right axillary local recurrence lesion was then resected, and she has since been treated with hormonal therapy of aromatase inhibitor (AI). The serum levels of tumor markers have been remarkably reduced, and FDG-PET/CT has showed the disappearance of the right axillary local recurrence, and the decrease of FDG accumulation of the right ovarian metastases in February 2007. We present a case of non-operated advanced breast cancer with local recurrence surviving successfully long term when treated with AI.
authors.affiliation: Dept. of Surgery, Kurashiki Central Hospital.
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Morimoto
authors.forename: Shiro
authors.initials: S
authors.lastname: Imai
authors.forename: Takuya
authors.initials: T
authors.lastname: Matsumoto
authors.forename: Mitsuhisa
authors.initials: M
authors.lastname: Kunisue
authors.forename: Seiichi
authors.initials: S
authors.lastname: Kawasaki
authors.forename: Kazushige
authors.initials: K
authors.lastname: Yamaguchi
authors.forename: Michio
authors.initials: M
authors.lastname: Okabe
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Kawamoto
authors.forename: Tadashi
authors.initials: T
authors.lastname: Ito
authors.forename: Keizo
authors.initials: K
authors.lastname: Ogasawara
mesh_terms: D000368:Aged; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000556:secondary
chemical_list: D047072:Aromatase Inhibitors; D014408:Biomarkers, Tumor